Display Settings:

Format

Send to:

Choose Destination
    Clin Infect Dis. 2008 Nov 1;47(9):1226-30.

    Drug toxicity, HIV progression, or comorbidity of aging: does tipranavir use increase the risk of intracranial hemorrhage?

    Source

    Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut 06516, USA.

    Abstract

    The US Food and Drug Administration has issued a warning that tipranavir may be associated with increased risk of intracranial hemorrhage. We studied 2 large cohorts to estimate the background rate of intracranial hemorrhage and compared it with rates reported among persons who had been exposed to tipranavir.

    PMID:
    18831696
    [PubMed - indexed for MEDLINE]
    Free full text

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk